DOI:
10.1055/s-00000167
International Journal of Angiology
LinksClose Window
References
Scharnagl H, Stojakovic T, Winkler K, Rosinger S, März W, Boehm BO.
The HMG-CoA reductase inhibitor cerivastatin lowers advanced glycation end products in patients with type 2 diabetes.
Exp Clin Endocrinol Diabetes 2007;
115 (6) 372-375
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.